» Articles » PMID: 21665296

Cholinergic Modulation of Dendritic Cell Function

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2011 Jun 14
PMID 21665296
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) are highly specialized antigen-presenting cells with a unique ability to activate resting T lymphocytes. Acetylcholine (ACh) is the primary parasympathetic neurotransmitter and also a non-neural paracrine factor produced by different cells. Here, we analyzed the expression of the cholinergic system in DCs. We found that DCs express the muscarinic receptors M(3), M(4) and M(5), as well as the enzymes responsible for the synthesis and degradation of ACh, choline acetyltransferase (ChAT) and acetylcholinesterase (AChE), respectively. Differentiation of DCs in the presence of the cholinergic agonist carbachol, the synthetic analog of ACh, resulted in an increased expression of HLA-DR and CD86 and the stimulation of TNF-α and IL-8 production. All these effects were prevented by atropine, a muscarinic ACh receptor (mAChR) antagonist. Carbachol, was also able to modulate the function of DCs when added after the differentiation is accomplished; it increased the expression of HLA-DR, improved the T cell priming ability of DCs, and stimulated the production of TNF-α but not IL-12 or IL-10. By contrast, carbachol significantly inhibited the stimulation of HLA-DR expression and the enhancement in the T cell priming ability of DCs triggered by LPS. Interestingly, the TNF-α antagonist etanercept completely prevented the increased expression of HLA-DR induced by carbachol, suggesting that it promotes the phenotypic maturation of DCs by stimulating the production of TNF-α. ACh induced similar effects than carbachol; it stimulated the expression of HLA-DR and the production of TNF-α, while inhibiting the stimulation of HLA-DR expression and IL-12 production triggered by LPS. Similarly, neostigmine, an inhibitor of AChE, also stimulated the expression of HLA-DR and the production of TNF-α by DCs while inhibiting the production of TNF-α and IL-12 triggered by LPS. These results support the existence of an autocrine/paracrine loop through which ACh modulates the function of DCs.

Citing Articles

Skin neuropathy and immunomodulation in diseases.

Zhang M, Liu T, Yang J Fundam Res. 2024; 4(2):218-225.

PMID: 38933512 PMC: 11197692. DOI: 10.1016/j.fmre.2022.08.016.


Contributions of Non-Neuronal Cholinergic Systems to the Regulation of Immune Cell Function, Highlighting the Role of α7 Nicotinic Acetylcholine Receptors.

Kawashima K, Mashimo M, Nomura A, Fujii T Int J Mol Sci. 2024; 25(8).

PMID: 38674149 PMC: 11050324. DOI: 10.3390/ijms25084564.


The diversity of neuroimmune circuits controlling lung inflammation.

Cremin M, Schreiber S, Murray K, Tay E, Reardon C Am J Physiol Lung Cell Mol Physiol. 2022; 324(1):L53-L63.

PMID: 36410021 PMC: 9829467. DOI: 10.1152/ajplung.00179.2022.


Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis.

Ren C, Yao R, Wang L, Li J, Chen K, Wu Y Front Pharmacol. 2021; 12:665579.

PMID: 34512319 PMC: 8427508. DOI: 10.3389/fphar.2021.665579.


Retinoic acid attenuates nuclear factor kappaB mediated induction of NLRP3 inflammasome.

Purbasari B, Madhyastha R, Madhyastha H, Nurrahmah Q, Maruyama M, Nakajima Y Pharmacol Rep. 2021; 74(1):189-203.

PMID: 34415562 DOI: 10.1007/s43440-021-00321-4.